Review highlights advances in cell-permeable nanobodies for intracellular targeting and therapeutic applications
Background
Nanobodies are promising biopharmaceuticals due to their small size, stability, and high target specificity. However, their therapeutic utility has been largely restricted to extracellular targets due to inefficient intracellular delivery methods. This limitation is significant, as many critical pathological targets for diseases like cancer, respiratory diseases, and neurological disorders reside within cells. Overcoming this delivery barrier is essential to unlock their full therapeutic potential.
Study Design
This comprehensive review synthesizes current research on diverse strategies for achieving cellular uptake of nanobodies and subsequent intracellular antigen recognition. The authors specifically emphasize the emerging potential of cell-permeable nanobodies as functional therapeutics. They discuss current challenges, translational clinical efforts, and future perspectives across relevant disease areas, including cancer, respiratory diseases, and neurological disorders.
Results
The review highlights significant advancements in strategies for intracellular delivery of nanobodies, enabling their access to previously inaccessible intracellular targets. It details various approaches, including direct membrane translocation, receptor-mediated endocytosis, and conjugation with cell-penetrating peptides. Crucially, the authors emphasize the demonstrated ability of these cell-permeable nanobodies to maintain antigen recognition and modulate cellular function once inside the cell. They also explore the application of these nanobodies for studying cellular pathways and tracking protein dynamics in live cells. The review further discusses the current challenges in optimizing delivery efficiency and minimizing off-target effects.
The synthesis of current literature underscores the transformative potential of cell-permeable nanobodies as functional therapeutics for challenging intracellular targets in cancer, respiratory diseases, and neurological disorders, moving beyond traditional extracellular applications.
Key Findings
- Diverse strategies for cellular uptake of nanobodies are advancing, enabling intracellular antigen recognition.
- Cell-permeable nanobodies show potential as functional therapeutics for cancer, respiratory, and neurological disorders.
- Review highlights current challenges, translational clinical efforts, and future perspectives for nanobody applications.
- Intracellular delivery methods include direct membrane translocation, receptor-mediated endocytosis, and cell-penetrating peptide conjugation.
Why It Matters
This review is crucial for researchers and developers, as it consolidates the diverse strategies for intracellular nanobody delivery, accelerating the development of novel therapeutics. For peptide users and biohackers, understanding these delivery mechanisms could inform future strategies for intracellular targeting of other biomolecules. The ability to effectively deliver nanobodies inside cells expands their utility beyond extracellular targets, potentially enabling precision modulation of intracellular pathways implicated in complex diseases. While still largely preclinical, the discussed translational efforts suggest that cell-permeable nanobodies could eventually offer highly specific and potent treatments for conditions like neurodegenerative disorders or intracellular infections where current therapies are limited.
nanobodies
intracellular delivery
cancer
respiratory diseases
neurological disorders
therapeutics
